SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome-Reference-Cited by-同舟云学术

SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome

Published:2022-04-22 Issue:9 Volume:46 Page:1277-1283
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Hasselblatt Martin,Thomas Christian,Federico Aniello,Nemes Karolina,Johann Pascal D.,Bison Brigitte,Bens Susanne,Dahlum Sonja,Kordes Uwe,Redlich Antje,Lessel Lienhard,Pajtler Kristian W.,Mawrin Christian,Schüller Ulrich,Nolte Kay,Kramm Christof M.,Hinz Felix,Sahm Felix,Giannini Caterina,Penkert Judith,Kratz Christian P.,Pfister Stefan M.,Siebert Reiner,Paulus Werner,Kool Marcel,Frühwald Michael C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference38 articles.

1. Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies;Frühwald;Neuro Oncol,2016

2. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity;Rorke;J Neurosurg,1996

3. Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup;Zin;Brain Pathol,2021

4. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors;Biegel;Cancer Res,1999

5. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms;Judkins;Am J Surg Pathol,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SWI/SNF-deficient tumors of the central nervous system: An update;Clinical Neuropathology;2024-01-01

2. Current Molecular and Clinical Landscape of ATRT – The Link to Future Therapies;Cancer Management and Research;2023-12

3. Artificial intelligence platform, RADR®, aids in the discovery of DNA damaging agent for the ultra-rare cancer Atypical Teratoid Rhabdoid Tumors;Frontiers in Drug Discovery;2022-10-11

4. Genome-Wide Identification and Characterization of the BRD Family in Nile Tilapia (Oreochromis niloticus);Animals;2022-09-01